The present invention relates to novel Salmonella mutants, to a process for producing the same and to vaccines containing the same, wherein said Salmonella mutants are characterized in that they are not responsive to stress-related recrudescence. It is accordingly an object of the present invention to provide the use of said Salmonella mutants in the vaccination of animals, in particular mammals and birds, more in particular pigs, poultry and cattle.
